151 related articles for article (PubMed ID: 12170133)
41. Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
Wales SQ; Smith CC; Wachsman M; Calton G; Aurelian L
Clin Diagn Lab Immunol; 2004 Jan; 11(1):42-9. PubMed ID: 14715543
[TBL] [Abstract][Full Text] [Related]
42. Performance of HSV-2 type specific serological tests in men in Kenya.
Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
[TBL] [Abstract][Full Text] [Related]
43. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.
Laeyendecker O; Henson C; Gray RH; Nguyen RH; Horne BJ; Wawer MJ; Serwadda D; Kiwanuka N; Morrow RA; Hogrefe W; Quinn TC
J Clin Microbiol; 2004 Apr; 42(4):1794-6. PubMed ID: 15071053
[TBL] [Abstract][Full Text] [Related]
44. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
45. Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK.
Narouz N; Allan PS; Wade AH; Wagstaffe S
Sex Transm Infect; 2003 Feb; 79(1):35-41. PubMed ID: 12576612
[TBL] [Abstract][Full Text] [Related]
46. Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults.
Zimet GD; Rosenthal SL; Fortenberry JD; Brady RC; Tu W; Wu J; Bernstein DI; Stanberry LR; Stone KM; Leichliter JS; Fife KH
Sex Transm Dis; 2004 Nov; 31(11):665-9. PubMed ID: 15502674
[TBL] [Abstract][Full Text] [Related]
47. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
[TBL] [Abstract][Full Text] [Related]
48. Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: A comparative study in Indian population from a tertiary care hospital.
Patwardhan V; Bhalla P
Indian J Pathol Microbiol; 2016; 59(3):318-21. PubMed ID: 27510668
[TBL] [Abstract][Full Text] [Related]
49. Type-specific detection of herpes simplex virus type 1 and type 2 using the cobas® HSV 1 and 2 test on the cobas® 4800 platform.
Van Der Pol B
Expert Rev Mol Diagn; 2016 Nov; 16(11):1145-1154. PubMed ID: 27687862
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.
Roest RW; van der Meijden WI; van Dijk G; Groen J; Mulder PG; Verjans GM; Osterhaus AD
Int J Epidemiol; 2001 Jun; 30(3):580-8. PubMed ID: 11416087
[TBL] [Abstract][Full Text] [Related]
51. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.
Reddy SM; Balakrishnan P; Uma S; Thyagarajan SP; Solomon S
Clin Diagn Lab Immunol; 2005 Feb; 12(2):359-60. PubMed ID: 15699434
[TBL] [Abstract][Full Text] [Related]
52. Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2).
Ashley Morrow R; Krantz E; Friedrich D; Wald A
J Clin Virol; 2006 Jun; 36(2):141-5. PubMed ID: 16677855
[TBL] [Abstract][Full Text] [Related]
53. Type-specific testing for herpes simplex virus.
Strick L; Wald A
Expert Rev Mol Diagn; 2004 Jul; 4(4):443-53. PubMed ID: 15225092
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors.
van de Laar MJ; Termorshuizen F; Slomka MJ; van Doornum GJ; Ossewaarde JM; Brown DW; Coutinho RA; van den Hoek JA
Int J Epidemiol; 1998 Feb; 27(1):127-34. PubMed ID: 9563706
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results.
Prince HE; Batterman HJ; Schwab DA
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114864. PubMed ID: 31395403
[TBL] [Abstract][Full Text] [Related]
56. Clinical uses of herpes simplex virus type-specific serology.
Munday PE; Mullan HM
Int J STD AIDS; 2001 Dec; 12(12):784-8. PubMed ID: 11779367
[TBL] [Abstract][Full Text] [Related]
57. Performance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spots.
García-Cisneros S; Sánchez-Alemán MÁ; Conde-Glez CJ; Lara-Zaragoza SJ; Herrera-Ortiz A; Plett-Torres T; Olamendi-Portugal M
J Infect Public Health; 2019; 12(2):224-228. PubMed ID: 30389368
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, san francisco, 2008.
Bohl DD; Katz KA; Bernstein K; Wong E; Raymond HF; Klausner JD; McFarland W
Sex Transm Dis; 2011 Jul; 38(7):617-21. PubMed ID: 21278625
[TBL] [Abstract][Full Text] [Related]
59. Testing for type-specific antibody to herpes simplex virus--implications for clinical practice.
Cowan FM
J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():9-13. PubMed ID: 10855767
[TBL] [Abstract][Full Text] [Related]
60. The acquisition of herpes simplex virus during pregnancy.
Brown ZA; Selke S; Zeh J; Kopelman J; Maslow A; Ashley RL; Watts DH; Berry S; Herd M; Corey L
N Engl J Med; 1997 Aug; 337(8):509-15. PubMed ID: 9262493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
